EX-15.1 7 filename7.htm

 

EXHIBIT 15.1

 

 

To the Board of Directors and Shareholders of

BioLingus (Cayman) Limited

 

LETTER IN LIEU OF CONSENT FOR REVIEW REPORT

 

We have reviewed, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the unaudited interim condensed consolidated financial information of BioLingus (Cayman) Limited for the periods ended October 31, 2022 and 2021, as indicated in our report dated March 24, 2023; because we did not perform an audit, we expressed no opinion on that information.

 

We also are aware that the aforementioned report, pursuant to Rule 436(c) under the Securities Act of 1933, is not considered a part of the Registration Statement prepared or certified by an accountant or a report prepared or certified by an accountant within the meaning of Sections 7 and 11 of that Act.

 

  /s/ WWC, P.C.
San Mateo, California WWC, P.C.
March 28, 2023 Certified Public Accountants